Zenas BioPharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ZBIO and other ETFs, options, and stocks.About ZBIO
Zenas BioPharma, Inc. is a clinical-stage global biopharmaceutical company, which engages in the development and commercialization of transformative immunology-based therapies for patients. The company was founded by Lonnie O.
CEOLeon Oliver Moulder
CEOLeon Oliver Moulder
Employees130
Employees130
HeadquartersWaltham, Massachusetts
HeadquartersWaltham, Massachusetts
Founded2019
Founded2019
Employees130
Employees130
ZBIO Key Statistics
Market cap2.05B
Market cap2.05B
Price-Earnings ratio-8.41
Price-Earnings ratio-8.41
Dividend yield—
Dividend yield—
Average volume297.01K
Average volume297.01K
High today$38.12
High today$38.12
Low today$35.68
Low today$35.68
Open price$36.62
Open price$36.62
Volume231.66K
Volume231.66K
52 Week high$41.00
52 Week high$41.00
52 Week low$5.83
52 Week low$5.83
Stock Snapshot
The current Zenas BioPharma(ZBIO) stock price is $38.11, with a market capitalization of 2.05B. The stock trades at a price-to-earnings (P/E) ratio of -8.41.
On 2025-12-05, Zenas BioPharma(ZBIO) stock moved within a range of $35.68 to $38.12. With shares now at $38.11, the stock is trading +6.8% above its intraday low and -0.0% below the session's peak.
Trading volume for Zenas BioPharma(ZBIO) stock has reached 231.66K, versus its average volume of 297.01K.
Over the past 52 weeks, Zenas BioPharma(ZBIO) stock has traded between a high of $41.00 and a low of $5.83.
Over the past 52 weeks, Zenas BioPharma(ZBIO) stock has traded between a high of $41.00 and a low of $5.83.
Analyst ratings
100%
of 8 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own ZBIO. This list is generated using Robinhood data, and it’s not a recommendation.